Journal of the Formosan Medical Association
Volume 105, Issue 2 , Pages 99-104, 2006

Association of p53 Codon 72 Polymorphism with Risk of Hypopharyngeal Squamous Cell Carcinoma in Taiwan

  • Chih-Wen Twu

      Affiliations

    • Institute of Clinical Medicine, National Yang-Ming University, Taipei
    • Department of Otolaryngology, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
    • ,
  • Rong-San Jiang

      Affiliations

    • Department of Otolaryngology, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
    • ,
  • Chih-Hung Shu

      Affiliations

    • Department of Otolaryngology, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
    • ,
  • Jin-Ching Lin

      Affiliations

    • Institute of Clinical Medicine, National Yang-Ming University, Taipei
    • Department of Radiation Oncology, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
    • Department of Radiation Oncology, National Cheng Kung University Hospital, Tainan, Taiwan, R.O.C.
    • Corresponding Author InformationCorrespondence to: Dr. Jin-Ching Lin, Department of Radiation Oncology, Taichung Veterans General Hospital, 160, Section 3, Taichung-Kang Road, Taichung 407, Taiwan, R.O.C.

Received 31 March 2005; received in revised form 2 May 2005; accepted 7 June 2005.

Article Outline

Background

p53 polymorphism at codon 72 is a known risk marker for various malignancies, but it has not been studied in hypopharyngeal cancer. This study investigated the genotype distribution of p53 codon 72 polymorphism in hypopharyngeal cancer patients and non-cancer controls matched for age, gender, alcohol consumption and smoking habit.

Methods

Genomic DNA was extracted from peripheral blood cells of 53 patients with hypopharyngeal cancer and 53 non-cancer controls. Codon 72 polymorphism of p53 was identified by polymerase chain reaction-restriction fragment length polymorphism.

Results

Patients with hypopharyngeal cancer had higher frequencies of Pro/Pro (26.4% vs. 13.2%) and Pro/Arg (51.0% vs. 45.3%) but lower frequencies of Arg/Arg (22.6% vs. 45.1%) compared to controls. Compared to Arg/Arg genotypes, Pro/Pro genotypes had a relative risk of hypopharyngeal cancer of 3.667 (95% confidence interval, 1.16-11.56; p = 0.03). As a group, patients with Pro/Pro or Arg/Pro who were carriers of the Pro allele had a higher relative risk of hypopharyngeal cancer compared to Arg homozygous carriers (odds ratio, 2.415; 95% confidence interval, 1.04-5.64; p = 0.04).

Conclusion

This study demonstrated that p53 codon 72 Pro homozygosity is associated with a higher risk of developing hypopharyngeal cancer.

Key Words:  hypopharyngeal cancer , p53 , polymorphism

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Hoffman HT , Karnell LH , Shap JP , et al.   Hypopharyngeal cancer patient care evaluation . Laryngoscope . 1997;107:1005–1017
  2. Ahomadegbe JC , Barrois M , Fogel S , et al.   High incidence of p53 alterations (mutations, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions . Oncogene . 1995;10:1217–1227
  3. Hauser U , Balz V , Carey TE , et al.   Reliable detection of p53 aberrations in squamous cell carcinomas of the head and neck requires transcript analysis of the entire coding region . Head Neck . 2002;24:868–873
  4. Matlashewski GJ , Tuck S , Pim D , et al.   Primary structure polymorphism at amino acid residue 72 of human p53 . Mol Cell Biol . 1987;7:961–963
  5. Storey A , Thomas M , Kalita A , et al.   Role of a p53 polymorphism in the development of human papillomavirus-associated cancer . Nature . 1998;393:229–234
  6. Madeleine MM , Shera K , Schwartz SM , et al.   The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer . Cancer Epidemiol Biomarkers Prev . 2000;9:225–227
  7. Tenti P , Vesentini N , Spaudo MR , et al.   p53 codon polymorphism does not affect the risk of cervical cancer in patients from northern Italy . Cancer Epidemiol Biomarkers Prev . 2000;9:435–438
  8. Andersson S , Rylander E , Strand A , et al.   The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas . Br J Cancer . 2001;85:1153–1156
  9. Zehbe I , Voglino G , Wilander E , et al.   Codon 72 polymorphism of p53 and its association with cervical cancer . Lancet . 1999;354:218–219
  10. Rosenthal AN , Ryan A , Al-Jehani RM , et al.   p53 codon 72 polymorphism and risk of cervical cancer in the UK . Lancet . 1998;352:871–875
  11. Sonoda Y , Saigo PE , Boyd J . p53 and genetic susceptibility to cervical cancer . J Natl Cancer Inst . 1999;91:557
  12. Papadakis ED , Soulitzis N , Spandidos DA . Association of p53 codon 72 polymorphism with advanced lung cancer: the Arg allele is preferentially retained in tumors arising in Arg/Pro germline heterozygotes . Br J Cancer . 2002;87:1013–1018
  13. Murata M , Tagawa M , Kimura M , et al.   Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history . Carcinogenesis . 1996;17:261–264
  14. Jin X , Wu X , Roth JA , et al.   Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype . Carcinogenesis . 1995;16:2205–2208
  15. Fan R , Wu MT , Miller D , et al.   The p53 codon 72 polymorphism and lung cancer risk . Cancer Epidemiol Biomarkers Prev . 2000;9:1037–1042
  16. Liu G , Miller DP , Zhou W , et al.   Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma . Cancer Res . 2001;61:8718–8722
  17. Kawajiri K , Nakachi K , Imai K , et al.   Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer . Carcinogenesis . 1993;14:1085–1089
  18. Wang YC , Chen CY , Chen SK , et al.   p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis . Clin Cancer Res . 1999;5:129–134
  19. Chen WC , Tsai FJ , Wu JY , et al.   Distribution of p53 codon 72 polymorphism in bladder cancer-proline form is prominent in invasive tumor . Urol Res . 2000;28:293–296
  20. Soulitzis N , Sourvinos G , Dokianakis DN , et al.   p53 codon polymorphism and its association with bladder cancer . Cancer Lett . 2002;179:175–183
  21. Toruner GA , Ucar A , Tez M , et al.   p53 codon 72 polymorphism in bladder cancer-no evidence of association with increased risk of invasiveness . Urol Res . 2001;29:393–395
  22. Henner WD , Evans AJ , Hough KM , et al.   Association of codon 72 polymorphism of p53 with lower prostate cancer risk . Prostate . 2001;49:263–266
  23. Chen YC , Xu L , Guo YL , et al.   Genetic polymorphism in p53 codon 72 and skin cancer in southwestern Taiwan . J Environ Sci Health (Part A) . 2003;38:201–211
  24. O'Connor DP , Kay EW , Leader M , et al.   p53 codon 72 polymorphism and human papillomavirus associated skin cancer . J Clin Pathol . 2001;54:539–542
  25. Kawaguchi H , Ohno S , Araki K , et al.   p53 polymorphism in human papillomavirus-associated esophageal cancer . Cancer Res . 2000;60:2753–2755
  26. Lee JM , Lee YC , Yang SY , et al.   Genetic polymorphisms of p53 and GSTP1, but not NAT2, are associated with susceptibility to squamous cell carcinoma of the esophagus . Int J Cancer . 2000;89:458–464
  27. Hiyama T , Tanaka S , Kitadai Y , et al.   p53 codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis . Int J Cancer . 2002;100:304–308
  28. Buyru N , Tigli H , Dalay N . p53 codon 72 polymorphism in breast cancer . Oncol Rep . 2003;10:711–714
  29. Papadakis EN , Dokianakis DN , Spandidos DA . p53 codon 72 polymorphism as a risk factor in the development of breast cancer . Mol Cell Biol Res Commun . 2000;3:389–392
  30. Sjalander A , Birgrander R , Hallmans G , et al.   p53 polymorphisms and haplotypes in breast cancer . Carcinogenesis . 1996;17:1313–1316
  31. Hamel N , Black MJ , Ghadirian P , et al.   No association between p53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck . Br J Cancer . 2000;82:757–759
  32. McWilliams JE , Evans AJ , Beer TM , et al.   Genetic polymorphisms in head and neck cancer risk . Head Neck . 2000;22:609–617
  33. Shen H , Zheng Y , Sturgis EM , et al.   p53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study . Cancer Lett . 2002;183:123–130
  34. Hollstein M , Sidransky D , Vogelstein B , et al.   p53 mutations in human cancers . Science . 1991;253:49–53
  35. Giaccia AJ , Kastan MB . The complexity of p53 modulation: emerging patterns from divergent signals . Gene Dev . 1998;12:2973–2983
  36. Vogelstein B , Kinsler K . p53 function and dysfunction . Cell . 1992;70:523–526
  37. Walker KK , Levine AJ . Identification of a novel p53 functional domain that is necessary for efficient growth suppression . Proc Natl Acad Sci USA . 1996;93:15335–15340
  38. Sakamuro D , Sabbatini P , White E , et al.   The polyproline region of p53 is required to activate apoptosis but not growth arrest . Oncogene . 1997;15:887–898
  39. Thomas M , Kalita A , Labrecque S , et al.   Two polymorphic variants of wild-type p53 differ biochemically and biologically . Mol Cell Biol . 1999;19:1092–1100
  40. Marin MC , Jost CA , Brooks LA , et al.   A common polymorphism acts as an intragenic modifier of mutant p53 behavior . Nat Genet . 2000;25:47–54
  41. Brooks LA , Tidy JA , Gusterson B , et al.   Preferential retention of codon 72 arginine in squamous cell carcinomas of the vulva occurs in cancers positive and negative for human papillomavirus . Cancer Res . 2000;60:6875–6877
  42. Koushik A , Platt RW , Franco EL . p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review . Cancer Epidemiol Biomarkers Prev . 2004;13:11–22
  43. Matakidou A , Eisen T , Houlston RS . TP53 polymorphisms and lung cancer risk: a systemic review and meta-analysis . Mutagenesis . 2003;18:377–385
  44. Summersgill KF , Smith EM , Kirchner HL , et al.   p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancer . Oral Surg Oral Med Oral Pathol Oral Radiol Endod . 2000;90:334–339
  45. Tandle AT , Sanghvi V , Saranath D . Determination of p53 genotypes in oral cancer patients from India . Br J Cancer . 2001;84:739–742
  46. Tsai MH , Lin CD , Hsieh YY , et al.   Prognostic significance of the proline form of p53 codon 72 polymorphism in nasopharyngeal carcinoma . Laryngoscope . 2002;112:116–119
  47. Sourvinos G , Rizos E , Spandidos DA . p53 codon 72 polymorphism is linked to the development and not the progression of benign and malignant laryngeal tumors . Oral Oncol . 2001;37:572–578
  48. Beckman G , Birgander R , Sjalander A , et al.   Is p53 polymorphism maintained by natural selection? . Hum Hered . 1994;44:266–270
  49. Weston A , Ling-Cawley HM , Caporaso NE , et al.   Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer . Carcinogenesis . 1994;15:583–587
  50. Wu MT , Liu CL , Ho CK , et al.   Genetic polymorphism of p53 and XRCC1 in cervical intraepithelial neoplasm in Taiwanese women . J Formos Med Assoc . 2004;103:337–343

PII: S0929-6646(09)60330-2

doi:10.1016/S0929-6646(09)60330-2

Journal of the Formosan Medical Association
Volume 105, Issue 2 , Pages 99-104, 2006

Article Tools